Loading organizations...
§ Private Profile · Burlington, MA, USA
Medical imaging company developing handheld ultrasound systems for healthcare professionals, focused on accessible medical imaging.
Butterfly Network develops handheld, single probe whole body ultrasound systems powered by semiconductor technology to provide portable medical imaging solutions for clinicians and hospitals. The publicly traded medical device company manufactures commercial hardware products like the Butterfly iQ, which is priced at approximately $2,000, to make diagnostic imaging accessible across diverse global healthcare markets. Prior to its February 2021 public listing on the New York Stock Exchange via a merger that established a $1.5 billion pro forma enterprise value, the organization secured over $400 million in private venture capital. This total included a $250 million funding round in 2018 that valued the enterprise at $1.25 billion, supported by prominent institutional investors such as the Bill and Melinda Gates Foundation, Fidelity, Fosun Pharma, and Baillie Gifford. Butterfly Network was founded in 2011 by Jonathan Rothberg and Nevada Sanchez.
Butterfly Network has raised $350.0M across 2 funding rounds.
Butterfly Network has raised $350.0M in total across 2 funding rounds.
Butterfly Network has raised $350.0M across 2 funding rounds. Most recently, it raised $250.0M Series D in September 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 27, 2018 | $250M Series D | Fidelity Management & Research Company | Jamie Dinan, Bill & Melinda Gates Foundation, Fosun Pharma | Announced |
| Nov 3, 2014 | $100M Venture Round | — | Aeris Capital, Stanford University | Announced |
Butterfly Network has raised $350.0M in total across 2 funding rounds.
Butterfly Network's investors include Fidelity Management & Research Company, Jamie Dinan, Bill & Melinda Gates Foundation, Fosun Pharma, Aeris Capital, Stanford University.